NYSE · traded in Congress
Corpay, CPAY
$444.5432 -10.6168 (-2.33%) Nov 9, 2026 4:00 AM ET
Market value$29.2B
P/E ratio-
Analyst target$470.00
52-week range-
Avg volumeN/A
Dividend yield-
Chart
Analyst ratings
- 16 buy
- 4 hold
- 0 sell
Low target$460.00
Average target$496.06
High target$550.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $586M | - | $175M | 29.9% | |
| $520M | - | $124M | 23.8% |
Congress trades in CPAY
Members of Congress disclosed 10 transactions in CPAY in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 08/07/2026 | April McClain Delaney MD06 | Sale | $15,001 - $50,000 | 9/9/2026 filing |
| 08/06/2026 | April McClain Delaney MD06 | Partial sale | $15,001 - $50,000 | 9/9/2026 filing |
| 08/03/2026 | April McClain Delaney MD06 | Partial sale | $1,001 - $15,000 | 9/9/2026 filing |
| 07/31/2026 | April McClain Delaney MD06 | Partial sale | $1,001 - $15,000 | 8/3/2026 filing |
| 07/30/2026 | April McClain Delaney MD06 | Partial sale | $1,001 - $15,000 | 8/3/2026 filing |
| 07/28/2026 | April McClain Delaney MD06 | Partial sale | $1,001 - $15,000 | 8/3/2026 filing |
| 07/17/2026 | April McClain Delaney MD06 | Partial sale | $1,001 - $15,000 | 8/3/2026 filing |
| 07/16/2026 | April McClain Delaney MD06 | Partial sale | $1,001 - $15,000 | 8/3/2026 filing |
| 07/15/2026 | April McClain Delaney MD06 | Partial sale | $1,001 - $15,000 | 8/3/2026 filing |
| 06/12/2026 | April McClain Delaney MD06 | Partial sale | $1,001 - $15,000 | 7/7/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
